Docs
🇬🇧
en
Mint Work
Sign in
Get Started
By
v1
A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases
Nicholas Fidelman
,
MD
NF
Nicholas Fidelman
NobleID
NI1P04W96R54S79
Type:
Journal Article
Claim Your Authorship
Cite
Sign in to see the full record
Creating an account is free.
Sign in
Create an account
For data access, contact
info@nobleid.org
.